Cost-Effectiveness of Everolimus for Second-Line Treatment of Metastatic Renal Cell Carcinoma in Serbia

星级：  14 页

efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma a registry-based analysis1

星级：  7 页

re phase ii trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell c

星级：  2 页

2007年班子述职述廉报告

星级：  8 页

Second-Line Treatment Outcomes After First-Line Sunitinib Therapy in Metastatic Renal Cell Carcinoma

星级：  6 页

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma

星级：  9 页

Comparison of Axitinib and Everolimus in the Second Line Treatment of Metastatic Renal Cell Carcinoma Following Previous Treatme

星级：  2 页

Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinoma

星级：  9 页

Second-line everolimus treatment in advanced renal-cell cancer

星级：  1 页